… (SSc) and idiopathic inflammatory myopathies (IIM) is known as Scleromyositis. Most cases of overlap are SSc-polymyositis/dermatomyositis. An…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 91 of 2459… gap. Interest in clinical trials of GLP-1 RAs as an adjunct to IBD therapy was high among both clinicians (90.4%) and eligible pat…
…ested by third-generation electrochemiluminescence immunoassay (Elecsys Anti-HCV II, Roche). A total of 3361 PLWH and 3361 age-comparable and sex-c…
…f tricyclic antidepressants (p=0.121), nor with the presence of type I diabetes (p=0.216). On an annual average, the prevalence of patients who…
… observed, suggesting an immune-mediated antitumor mechanism of CJRB-101. A total of 42 patients were enrolled in the low-dose cohort (o…
…partum period, breastfeeding rates and their possible impact on rheumatoid arthritis (RA) and spondyloarthritis (SpA) activity.Method This ancillary…
…re treated with vaccine on days 1 and 8 of a 3 week cycle, with pembrolizumab given on day 1 of each cycle. Patients in Arm A (n=30) received…
…pital. Migraine-related variables—monthly migraine days (MMDs), Visual Analogue Scale (VAS), Headache Impact Test-6 (HIT-6) and use of prophylactic m…
…nt learnings come from traditionally designed large prospective asthma cohorts, highly restrictive inclusion and exclusion criteria li…
…een put forward for consideration in treating high-risk TA-TMA; eculizumab, narsopilmab, rituximab, defibrotide, ravulizumab, nomacopan, p…
…send Deprivation Index and unemployment) and 15 APOs, including gestational diabetes, gestational hypertension, spontaneous abortion, ectopic pregna…